Over time, linking organ-on-chip data, in silico digestion models and AI-based hazard prediction into a single safety-by-design pipeline would move nanoencapsulation from case-by-case evaluations toward more systematic, evidence-based development
Weight loss achieved through GLP-1 therapy contributes significantly to improved lipid profiles, as adipose tissue reduction typically correlates with favourable changes in cholesterol levels
Betaine suppresses lipid accumulation in liver: inhibition of FoxO6 and PPAR interaction
Abstract The gut microbiota, which includes Akkermansia muciniphila , is known to modulate energy metabolism, glucose tolerance, immune system maturation and function in humans 1,2,3,4
Data are in line with results in randomised controlled trials and show the long-term stable benefit of once weekly semaglutide. In August, Novo Nordisk published the findings of its own five-year study on Wegovy, known as the Select trial